West Oak Capital’s GSK GSK Stock Holding History

West Oak Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-88	Closed	-$4.47K	–	314
2017 Q3	$4.47K	Hold	88	–	–	﹤0.01%	295
2017 Q2	$4.74K	Hold	88	–	–	﹤0.01%	311
2017 Q1	$4.64K	Hold	88	–	–	﹤0.01%	330
2016 Q4	$4.24K	Sell	88 -100	-53%	-$4.94K	﹤0.01%	305
2016 Q3	$10.1K	Buy	188 +100	+114%	+$5.48K	0.01%	293
2016 Q2	$4.77K	Hold	88	–	–	﹤0.01%	293
2016 Q1	$4.46K	Hold	88	–	–	﹤0.01%	231
2015 Q4	$4.44K	Hold	88	–	–	﹤0.01%	239
2015 Q3	$4.23K	Hold	88	–	–	﹤0.01%	239
2015 Q2	$4.58K	Hold	88	–	–	﹤0.01%	240
2015 Q1	$5.08K	Sell	88 -449	-84%	-$25.7K	﹤0.01%	237
2014 Q4	$28.7K	Buy	537 +449	+510%	+$25.1K	0.02%	185
2014 Q3	$5.06K	Hold	88	–	–	﹤0.01%	230
2014 Q2	$5.88K	Hold	88	–	–	﹤0.01%	225
2014 Q1	$5.88K	Hold	88	–	–	﹤0.01%	222
2013 Q4	$5.87K	Hold	88	–	–	﹤0.01%	222
2013 Q3	$5.52K	Hold	88	–	–	﹤0.01%	219
2013 Q2	$5.5K	Buy	+88	New	+$5.58K	﹤0.01%	216

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

West Oak Capital's GSK Position: Q4 2017 in Review

West Oak Capital sold out of GSK (GSK) in Q4 2017, closing a stake of 88 shares — an estimated $4.47K sold.

West Oak Capital first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $28.7K in Q4 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

West Oak Capital reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
West Oak Capital sold 88 GSK shares in Q4 2017, an estimated $4.47K.
West Oak Capital first reported a position in GSK in Q2 2013 and held it in 18 quarters.
West Oak Capital's GSK position peaked at $28.7K in Q4 2014.
763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on West Oak Capital's 13F filing for Q4 2017, filed 5 Jan 2018.